Scientific Advisory Board
|
The AerovectRx Corporation board of advisors represents some of the
innovative and dedicated researchers in the field of respiratory care and
aerosol drug delivery.
|
Kenneth Brigham, M.D. (Chair). Dr. Brigham served as Ralph and Lulu
|
Owen Professor Pulmonary Medicine and Director of the Center for Lung
Research and the Division of Allergy Pulmonary and Critical Care Medicine at
Vanderbilt University from 1973 until he joined the Emory University faculty
in 2002 as Vice Chairman of the Department of Medicine. Dr. Brigham is also
Associate Director for Research McKelvey Lung Transplantation Center;
Director of a new Center for Translational Research in the Lung; and Interim
Director Predictive Health Initiative. He is a previous President of the
American Thoracic Society, has chaired several National Institutes of Health
review committees and served on the editorial board of many scholarly
journals.
|
Robert Aris, M.D. Dr. Aris currently serves as an Associate Professor of
|
Medicine at the University of North Carolina at Chapel Hill while also serving
as Director at the Pulmonary Hypertension Clinic and as Director at the Lung
Transplantation Immunology Laboratory. Dr. Aris has authored or
co-authored over 80 publications on the topic of pulmonary function and lung
disease and has been invited to present at numerous industry events and
serves or has served on the editorial board of journals such as CHEST,
Current Respiratory Medicine Reviews, American Journal of Respiratory and
Critical Care Medicine, and The Open Respiratory Medicine Journal.
|
James J. Barry, Ph.D. Dr. Barry is a principal and President of Creare, Inc.,
|
CDC contract recipient and SBIR and STTR recipient for the development of
the nebulizer technology licensed from the CDC. As co-inventor of the
technology assigned to the CDC for the nebulizer technology, Dr. Barry
provides necessary know-how and trade secrets to facilitate AerovectRx’s
commercialization of the technology.
|
Beth L. Laube, Ph.D. Dr. Laube holds a Ph.D. from the Johns Hopkins
|
Bloomberg School of Public Health in Baltimore, Maryland and is currently an
Associate Professor of Pediatrics at the Johns Hopkins School of Medicine. Dr.
Laube is President of the International Society for Aerosols in Medicine (ISAM)
and is a member of the American Thoracic Society. She serves on the
Editorial Board of the Journal of Aerosol Medicine, on the advisory committee
to the World Health Organization Product Development Group for the
Aerosolized Measles Vaccine Project and on the National Academy of Science’s
Committee on Animal Models for Testing Interventions Against Aerosolized
Bioterrorism Agents. Dr. Laube is a frequent advisor to pre-doctoral
candidates and post-doctoral fellows at the Johns Hopkins University and at
the University of Maryland and has published over 40 peer-reviewed articles.
|
Ralph Tripp, Ph.D. Dr.Tripp brings over 17 years of research experience in
|
the field of influenza and respiratory virology studies and related intervention
experiences. Prior to becoming a professor at the University of Georgia
veterinary school in the department of infectious diseases and Vaccine Chair
for the Georgia Research Alliance, Dr. Tripp served at the Centers for Disease
Control as section chief of the Respiratory and Enteric Viruses Branch.
|
Gerald Smaldone, M.D., Ph.D. Dr. Smaldone is one of the leading experts
|
in the field of aerosol medicine with numerous publications, patents, and
presentations in this field. After receiving a Bachelors of Engineering in
Chemical Engineering at New York University School of Engineering and
Science, he later received his doctorate in medicine as well as his Ph.D. in
Physiology at New York University School of Medicine. In addition to his
consulting activities, Dr. Smaldone regularly serves as Chief of the
Pulmonary/Critical Care Division at SUNY Stony Brook while also teaching as
a Professor or Medicine, Physiology and Biophysics for the medical school.
Dr. Smaldone is an active member of the International Society for Aerosol
Medicine and is the founding editor of Journal of Aerosol Medicine.
|
Arlene Stecenko, M.D. Prior to joining the Department of Medicine at Emory
|
University as Associate Professor of Medicine in 2002, Dr. Stecenko served on
the Vanderbilt University Faculty as Associate Professor Medicine. She was
formerly Chief of the Division of Pediatric Pulmonary Medicine at the
University of Florida Medical Center in Gainesville. She is currently Division
Chief, Pulmonary, Allergy, Cystic Fibrosis and Sleep, Department of
Pediatrics; Director the Emory University Cystic Fibrosis Center, and
Investigator for the McKelvey Lung Transplantation Center.
|
SAB Observer
|
Mark Papania, MD, M.P.H. Dr. Papania is the primary inventor for the CDC
|
licensed technology. Dr. Papania brings over 20 years of experience in public
health and epidemiology with special emphasis on infectious diseases and
measles in particular.
|
Members of the AerovectRx Scientific Advisory Board are compensated for their time and are
independent of the company. Listing of the affiliated institutions by the respective members of the
Scientific Advisory Board does not necessarily reflect an endorsement by those institutions.
|
